Pyridostigmine Bromide

Drug Class: Cholinergic and Anticholinesterase Agents
Dosage Form: Tablet
Strength: 60mg, 180mg (sustained release
Indications/Special comments: Myasthenia gravis
Dosage Administration: Initially 200–400 mg daily in divided doses until the patient becomes euthyroid, then reduced to 50–150 mg daily in divided doses, initial dose should be gradually reduced to the maintenance dose.